What is Cooper Creek Partners Management's new investment in Chemours?

Cooper Creek Partners Management acquired nearly 4 million shares of The Chemours Company, valued at $63.1 million, during the third quarter.

How has The Chemours Company stock performed recently?

Chemours stock has experienced a significant downturn, with shares down 41% over the past year, underperforming the S&P 500.

What products does The Chemours Company offer?

The Chemours Company produces titanium dioxide pigments, refrigerants, advanced performance materials, and industrial chemicals, including brands like Ti-Pure.

Home / Business and Economy / Fund Buys Millions in Falling Chemours Stock

Fund Buys Millions in Falling Chemours Stock

1 Dec, 2025

•

Summary

Cooper Creek Partners Management acquired nearly 4 million Chemours shares.
The new position was valued at $63.1 million as of September 30.
Chemours stock is down 41% over the past year.

Fund Buys Millions in Falling Chemours Stock

In the third quarter, New York City-based Cooper Creek Partners Management established a notable new stake in The Chemours Company. Regulatory filings revealed the acquisition of almost 4 million shares, amounting to an investment of $63.1 million by the end of September. This strategic move represented 1.9% of Cooper Creek's total reported assets under management for the period.

Chemours, a producer of titanium dioxide pigments and refrigerants, has faced significant market headwinds. As of Friday's closing bell, its shares were priced at $12.79, marking a 41% decrease over the preceding year. This performance starkly contrasts with the broader S&P 500's 14% gain during the same timeframe.